Henry Schein Cash Flow from Operating Activities 2012-2026 | HSIC
Henry Schein annual/quarterly cash flow from operating activities history and growth rate from 2012 to 2026. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Henry Schein cash flow from operating activities for the quarter ending March 31, 2026 was $712M, a 16.04% decline year-over-year.
- Henry Schein cash flow from operating activities for the twelve months ending March 31, 2026 was $1.237B, a 43.31% decline year-over-year.
- Henry Schein annual cash flow from operating activities for 2025 was $0.712B, a 16.04% decline from 2024.
- Henry Schein annual cash flow from operating activities for 2024 was $0.848B, a 69.6% increase from 2023.
- Henry Schein annual cash flow from operating activities for 2023 was $0.5B, a 16.94% decline from 2022.
|
Henry Schein Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2025 | $712 |
| 2024 | $848 |
| 2023 | $500 |
| 2022 | $602 |
| 2021 | $710 |
| 2020 | $599 |
| 2019 | $654 |
| 2018 | $685 |
| 2017 | $546 |
| 2016 | $643 |
| 2015 | $616 |
| 2014 | $593 |
| 2013 | $664 |
| 2012 | $408 |
| 2011 | $555 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $8.645B | $13.184B |
| Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |